FDA approves Alzheimer's drug, bringing thousands of Nebraskans 'a lot of hope'

Trial results showed that the drug Lecanemab - more commonly called Leqembi - slowed the progression of the disease for those with early-onset symptoms.

Related Keywords

Nebraska ,United States ,Nebraskans ,Nick Faustman ,Mckenzie Johnson ,Drug Administration ,Alzheimer Association Nebraska Chapter ,Kenzie Johnson ,Association Nebraska ,